Chimaobi M Anugwom

Chimaobi M Anugwom, MD, is an Assistant Professor in the Medicine - Gastroenterology, Hepatology, and Nutrition Division at the University of Minnesota. His research is centered on liver diseases, particularly hepatocellular carcinoma, hepatitis B, and acute liver failure, with a strong emphasis on global health epidemiology and transplant outcomes. His work spans across Africa, South America, and immigrant populations in the United States.

Research Interests:

• Hepatocellular carcinoma surveillance and epidemiology in under-resourced regions
• Hepatitis B treatment outcomes in Ethiopia and other African nations
• Acute liver failure and liver transplant outcomes
• Genetic and immune factors in liver disease progression
• Health disparities in immigrant populations

His recent publications reflect a strong focus on global liver disease epidemiology, with studies in The Lancet Gastroenterology & Hepatology, Annals of Hepatology, and Cancers. These works highlight the shifting burden of liver cancer in South America, the role of STAT4 variants in HCC risk, and the socioeconomic determinants of hepatitis B treatment in Ethiopia.

Scientific Contributions:

• Over 35 peer-reviewed publications since 2018
• Collaborations across Africa, South America, and the U.S.
• Focus on translational and epidemiological research in hepatology

Clinical and Academic Roles:

Dr. Anugwom is actively engaged in both clinical practice and academic research. His affiliations include the University of Minnesota Medical School, where he contributes to both education and patient care in gastroenterology and hepatology. His work aligns with UN Sustainable Development Goals, particularly in reducing health disparities and improving outcomes in liver disease globally.